Bond Barclay PLC 0.03125% ( XS1550975079 ) in GBP

Issuer Barclay PLC
Market price 100 %  ▲ 
Country  United Kingdom
ISIN code  XS1550975079 ( in GBP )
Interest rate 0.03125% per year ( payment 1 time a year)
Maturity 17/01/2024 - Bond has expired



Prospectus brochure of the bond Barclays PLC XS1550975079 in GBP 0.03125%, expired


Minimal amount /
Total amount /
Detailed description Barclays PLC is a British multinational banking and financial services corporation headquartered in London, offering a wide range of services including personal and corporate banking, investment banking, and wealth management.

The Bond issued by Barclay PLC ( United Kingdom ) , in GBP, with the ISIN code XS1550975079, pays a coupon of 0.03125% per year.
The coupons are paid 1 time per year and the Bond maturity is 17/01/2024







Drawdown Prospectus dated 13 January 2017

BARCLAYS PLC
(incorporated with limited liability in England and Wales)

Issue of £600,000,000 3.125 per cent. Notes due 2024
(the "Notes")
Issue Price: 99.560 per cent.
issued pursuant to the £60,000,000,000 Debt Issuance Programme of Barclays PLC and Barclays
Bank PLC (the "Programme")
This drawdown prospectus (the "Prospectus") (which must, unless otherwise expressly set out herein, be read and
construed as one document in conjunction with all documents incorporated by reference herein, including the sections
of the base prospectus dated 3 August 2016 as supplemented by Supplement Number 1 to the base prospectus dated
28 October 2016 (together, the "Base Prospectus"), see "Information Incorporated by Reference") is prepared in
connection with the issue of £600,000,000 aggregate principal amount of 3.125 per cent. Notes due 17 January 2024
(the "Notes") by Barclays PLC (the "Issuer", the "Company" or "Barclays") under the Programme. Terms used but
not defined in this Prospectus shall have the same respective meanings as are ascribed to them in the Terms and
Conditions of the Notes (the "Conditions") set out in "Terms and Conditions of the Notes" below.
From and including 17 January 2017 (the "Issue Date"), interest will accrue on the Notes at a rate of 3.125 per cent.
per annum. Interest will be payable annually in arrear on 17 January of each year (each an "Interest Payment
Date"), commencing on 17 January 2018.
The Notes will constitute the Issuer's direct, unconditional, unsecured and unsubordinated obligations, which will at
all times rank pari passu among themselves and, in the event of the winding up or administration of the Issuer will
rank pari passu with all other present and future unsecured and unsubordinated obligations of the Issuer, save for
such obligations as may be preferred by provisions of law.
Unless previously redeemed or otherwise cancelled, the Notes will mature on 17 January 2024 (the "Maturity
Date"). The Notes may be redeemed at the option of the Issuer in whole or in part during the period from and
including 17 July 2017 to but excluding the Maturity Date, at the Make Whole Redemption Price, together with any
accrued but unpaid interest to (but excluding) the date fixed for redemption. The Issuer may also redeem the Notes, in
whole but not in part, at any time at 100 per cent. of their outstanding principal amount, together with any accrued but
unpaid interest to (but excluding) the date fixed for redemption, upon the occurrence of certain tax events as
described in Condition 10(b) (Redemption for tax reasons). Any such redemption may be subject to the PRA's prior
consent (if such consent is then required by the Capital Regulations).
Application has been made for this Prospectus to be approved by the United Kingdom Financial Conduct Authority
(the "FCA") under Part VI of the Financial Services and Markets Act 2000, as amended ("FSMA") as a prospectus
issued in compliance with Directive 2003/71/EC, as amended (the "Prospectus Directive") and relevant
implementing measures in the United Kingdom for the purpose of giving information with regard to the issue of the
Notes. This Prospectus comprises a prospectus for the purpose of Article 5.4 of the Prospectus Directive.
Applications have been made for the Notes to be admitted to listing on the Official List of the FCA (the "Official
List") and to trading on the Regulated Market of the London Stock Exchange plc (the "London Stock Exchange")
on or about the Issue Date. The Regulated Market of the London Stock Exchange is a regulated market for the
purposes of Directive 2004/39/EC on markets in financial instruments (the "Market"). References in this Prospectus
to Notes being "listed" (and all related references) shall, unless the context otherwise requires, mean that the Notes
have been admitted to the Official List and admitted to trading on the Market.
The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the
"Securities Act"). The Notes are being offered outside the United States by the Managers (as defined below) in
accordance with Regulation S under the Securities Act ("Regulation S"), and may not be offered, sold or delivered
within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or
in a transaction not subject to, the registration requirements of the Securities Act.
The Notes will be in registered form in denominations of £100,000 and integral multiples of £1,000 in excess thereof.
The Notes will be represented by an Unrestricted Global Certificate and will be sold outside the United States to
non-U.S. persons in reliance on Regulation S. The Notes represented by the Unrestricted Global Certificate will be
87441-3-17448-v13.0
- i-
70-40643095



registered in the name of a common safekeeper (or its nominee) for Clearstream Banking, S.A. ("Clearstream,
Luxembourg") and/or Euroclear Bank S.A./N.V. ("Euroclear" and, together with Clearstream, Luxembourg, the
"Clearing Systems") and deposited on or about the Issue Date with such common safekeeper. Beneficial interests in
the Notes will be held through Clearstream, Luxembourg and/or Euroclear and their respective direct and indirect
participants, and such direct and indirect participants will record beneficial interests on their books. The Issuer will
not issue individual certificates in respect of the Notes except in the limited circumstances set out in "Forms of the
Notes ­ Global Certificate exchangeable for Individual Certificates" in the Base Prospectus (incorporated by
reference herein). Settlement of the Notes will occur through the Clearing Systems against payment for value on 17
January 2017.
The Notes are not deposit liabilities of the Issuer and are not covered by the United Kingdom Financial Services
Compensation Scheme or insured by the U.S. Federal Deposit Insurance Corporation or any other governmental
agency of the United States, the United Kingdom or any other jurisdiction.
The Notes are expected to be rated BBB, Baa2 and A, respectively by Standard & Poor's Credit Market Services
Europe Limited ("Standard & Poors"), Moody's Investors Service Ltd. ("Moody's") and Fitch Ratings Limited
("Fitch"), each of which are established in the European Union and registered under Regulation (EC) No 1060/2009,
as amended (the "CRA Regulation"). A security rating is not a recommendation to buy, sell or hold securities
and may be subject to suspension, reduction or withdrawal at any time by the assigning rating agency.
Investing in the Notes involves certain risks. The principal risk factors that may affect the ability of the Issuer to
fulfil its obligations under the Notes are discussed under "Risk Factors" below.
Lead Manager
BARCLAYS BANK PLC
Co-Managers
BANCA IMI S.P.A.
BANCO POPULAR ESPAÑOL, S.A.
BANCO SANTANDER, S.A.
BANK OF CHINA LIMITED, LONDON
BRANCH
BANK OF MONTREAL, LONDON BRANCH
BNY MELLON CAPITAL MARKETS EMEA
LIMITED
COÖPERATIEVE RABOBANK U.A.
ERSTE GROUP BANK AG
LANDESBANK BADEN-WÜRTTEMBERG
LLOYDS BANK PLC
NATIONAL AUSTRALIA BANK LIMITED
NATIXIS SA
NOMURA INTERNATIONAL PLC
NORDEA BANK AB (PUBL)
SCOTIABANK EUROPE PLC
SMBC NIKKO CAPITAL MARKETS LIMITED
STANDARD CHARTERED BANK
SWEDBANK AB (PUBL)
UNITED OVERSEAS BANK LIMITED



87441-3-17448-v13.0
- ii-
70-40643095



IMPORTANT NOTICES
The Issuer accepts responsibility for the information contained in this Prospectus. The Issuer declares
that, having taken all reasonable care to ensure that such is the case, the information contained in this
Prospectus is, to the best of its knowledge, in accordance with the facts and contains no omission likely to
affect its import.
Terms used but not defined in this Prospectus shall have the same respective meaning as are ascribed to
them in the Base Prospectus sections incorporated by reference herein.
This Prospectus must be read and construed with any information incorporated by reference herein (see
"Information Incorporated by Reference" below).
The Issuer has confirmed to the Managers (as defined below) that this Prospectus contains all information
with regard to it and its subsidiaries which is (in the context of the issue, offering and sale of the Notes)
material, such information is true and accurate in all material respects and is not misleading and does not
omit to state any other fact required (in the context of the issue, offering and sale of the Notes) to be
stated herein or the omission of which would make any information contained herein misleading in any
material respect and that all reasonable enquiries have been made to ascertain such facts and to verify the
accuracy of all such information.
To the fullest extent permitted by law, none of Barclays Bank PLC (the "Lead Manager") and Banca
IMI S.p.A., Banco Popular Español, S.A., Banco Santander, S.A., Bank of China Limited, London
Branch, Bank of Montreal, London Branch, BNY Mellon Capital Markets EMEA Limited, Coöperatieve
Rabobank U.A., Erste Group Bank AG, Landesbank Baden-Württemberg, Lloyds Bank plc, National
Australia Bank Limited (ABN 12 004 044 937), Natixis S.A, Nomura International plc, Nordea Bank AB
(publ), Scotiabank Europe plc, SMBC Nikko Capital Markets Limited, Standard Chartered Bank,
Swedbank AB (publ) and United Overseas Bank Limited (together with the Lead Manager, the
"Managers") or The Bank of New York Mellon, London Branch (the "Trustee") accept any
responsibility for the contents of this Prospectus or for any other statement, made or purported to be made
by the Trustee or a Manager or on its behalf in connection with the Issuer or the issue and offering of the
Notes. The Trustee and each Manager accordingly disclaim all and any liability whether arising in tort or
contract or otherwise (save as referred to above) which any of them might otherwise have in respect of
this Prospectus or any such statement. The statements made in this paragraph are without prejudice to the
responsibilities of the Issuer under or in connection with the Notes.
Unauthorised Information
No person has been authorised to give any information or to make any representation not contained in or
not consistent with this Prospectus or such other information as is in the public domain and, if given or
made, such information or representation should not be relied upon as having been authorised by the
Issuer, the Trustee or any Manager.
Neither the Managers nor any of their respective affiliates, nor the Trustee have authorised the whole or
any part of this Prospectus and none of them makes any representation or warranty or accepts any
responsibility as to the accuracy or completeness of the information contained in this Prospectus. Neither
the delivery of this Prospectus nor the offering, sale or delivery of any Note shall, in any circumstances,
create any implication that the information contained in this Prospectus is true subsequent to the date
hereof or that there has been no adverse change, or any event reasonably likely to involve any adverse
change, in the prospects or financial or trading position of the Issuer since the date thereof, or that any
other information supplied in connection with the Notes is correct at any time subsequent to the date on
which it is supplied or, if different, the date indicated in the document containing the same. The Managers
and the Trustee expressly do not undertake to review the financial condition or affairs of the Issuer during
the life of the Notes nor to advise any investor or potential investor in the Notes of any information
coming to the attention of any of the Managers or the Trustee. Investors should review, inter alia, the
most recent published financial statements of the Issuer when evaluating the Notes.
Restrictions on distribution
The distribution of this Prospectus and the offering, sale and delivery of the Notes in certain jurisdictions
may be restricted by law. Persons into whose possession this Prospectus comes are required by the Issuer
87441-3-17448-v13.0
- iii-
70-40643095



and the Managers to inform themselves about and to observe any such restrictions. For a description of
certain restrictions on offers, sales and deliveries of Notes and on the distribution of this Prospectus and
other offering material relating to the Notes, see "Subscription and Sale" below and "Transfer
Restrictions" incorporated by reference herein.
The Notes have not been and will not be registered under the Securities Act or with any securities
regulatory authority of any state or other jurisdiction of the United States. The Notes may not be offered
or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an
exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The
Notes are being offered and sold in registered form and are being offered and sold outside the United
States to non-U.S. persons in reliance on Regulation S. This Prospectus may not be used for the purpose
of an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not
authorised or to any person to whom it is unlawful to make such offer or solicitation.
Neither this Prospectus nor any of the documents incorporated herein by reference constitutes an offer or
an invitation to subscribe for or purchase any Notes and are not intended to provide the basis of any credit
or other evaluation and should not be considered as a recommendation by any of the Issuer, the Trustee or
any of the Managers or any of them that any recipient of this Prospectus should subscribe for or purchase
any Notes. Each recipient of this Prospectus shall be taken to have made its own investigation and
appraisal of the condition (financial or otherwise) of the Issuer.
The Notes are complex financial instruments and such instruments may be purchased by investors as a
way to reduce risk or enhance yield with an understood, measured, appropriate addition of risk to their
overall portfolios. Each potential investor in the Notes must determine the suitability of that investment
in light of its own circumstances. In particular, each potential investor should:
(i)
have sufficient knowledge and experience to make a meaningful evaluation of the Notes, the
merits and risk of investing in the Notes and the information contained or incorporated by
reference in this Prospectus;
(ii)
have access to, and knowledge of, appropriate analytical tools to evaluate, in the context of its
particular financial situation, an investment in the Notes and the impact such investment will
have on its overall investment portfolio;
(iii)
have sufficient financial resources and liquidity to bear all of the risks of an investment in the
Notes or where the currency for principal and interest payments is different from the currency in
which such investor's financial activities are principally denominated;
(iv)
understand thoroughly the terms of the Notes and be familiar with the behaviour of any relevant
indices and financial markets; and
(v)
be able to evaluate (either alone or with the help of a financial adviser) possible scenarios for
economic, interest rate and other factors that may affect its investment and its ability to bear the
applicable risks.
The investment activities of certain investors are subject to legal investment laws and regulations, or
review or regulation by certain authorities. Each potential investor should consult its legal advisers to
determine whether and to what extent: (i) Notes are legal investments for it; (ii) Notes can be used as
collateral for various types of borrowing; and (iii) other restrictions apply to its purchase or pledge of any
Notes. Financial institutions should consult their legal advisers or the appropriate regulators to determine
the appropriate treatment of the Notes under any applicable risk-based capital or similar rules.
Currency definitions
In this Prospectus, references to (i) "£", "GBP" or "pounds sterling" are to the lawful currency for the
time being of the United Kingdom and Northern Ireland.
Certain figures included in this Prospectus have been subject to rounding adjustments; accordingly,
figures shown for the same category presented in different tables may vary slightly and figures shown as
totals in certain tables may not be an arithmetic aggregation of the figures which precede them.

87441-3-17448-v13.0
- iv-
70-40643095



Stabilisation
In connection with the issue of the Notes, Barclays Bank PLC acting as the Stabilising Manager
(the "Stabilising Manager") may over allot Notes or effect transactions with a view to supporting
the market price of the Notes at a level higher than that which might otherwise prevail. However,
there is no assurance that the Stabilising Manager (or persons acting on behalf of a Stabilising
Manager) will undertake stabilisation action.
Any stabilisation action may begin on or after the date on which adequate public disclosure of the
terms of the offer of the Notes is made and, if begun, may be ended at any time, but it must end no
later than the earlier of 30 days after the issue date of the Notes and 60 days after the date of the
allotment of the Notes. Any stabilisation action or over-allotment must be conducted by the
Stabilising Manager (or person(s) acting on behalf of any Stabilising Manager) in accordance with
all applicable laws and rules.
FORWARD-LOOKING STATEMENTS
This Prospectus and certain documents incorporated by reference herein contain certain forward-looking
statements within the meaning of Section 21E of the U.S. Securities Exchange Act of 1934, as amended,
and Section 27A of the Securities Act, with respect to the Issuer and its consolidated subsidiaries (the
"Group"). The Issuer cautions readers that no forward-looking statement is a guarantee of future
performance and that actual results or other financial condition or performance measures could differ
materially from those contained in the forward-looking statements. These forward-looking statements can
be identified by the fact that they do not relate only to historical or current facts. Forward-looking
statements sometimes use words such as "may", "will", "seek", "continue", "aim", "anticipate", "target",
"projected", "expect", "estimate", "intend", "plan", "goal", "believe", "achieve" or other words of similar
meaning. Examples of forward-looking statements include, among others, statements or guidance
regarding the Group's future financial position, income growth, assets, impairment charges, provisions,
notable items, business strategy, capital, leverage and other regulatory ratios, payment of dividends
(including dividend pay-out ratios and expected payment strategies), projected levels of growth in the
banking and financial markets, projected costs or savings, original and revised commitments and targets
in connection with the strategic cost programme, the March 2016 Group Strategy Update (as defined in
the "Information Incorporated by Reference" section below), rundown of assets and businesses within
Barclays Non-Core (as such unit is described in the Joint Annual Report (as defined in the "Information
Incorporated by Reference" section below)), sell down of the Group's interest in Barclays Africa Group
Limited, estimates of capital expenditures and plans and objectives for future operations, projected
employee numbers and other statements that are not historical fact.
By their nature, forward-looking statements involve risk and uncertainty because they relate to future
events and circumstances. These may be affected by changes in legislation, the development of standards
and interpretations under International Financial Reporting Standards, evolving practices with regard to
the interpretation and application of accounting and regulatory standards, the outcome of current and
future legal proceedings and regulatory investigations, future levels of conduct provisions, future levels of
notable items, the policies and actions of governmental and regulatory authorities, geopolitical risks and
the impact of competition. In addition, factors including (but not limited to) the following may have an
effect: capital, leverage and other regulatory rules (including with regard to the future structure of the
Group) applicable to past, current and future periods; the United Kingdom ("UK"), the United States
("U.S."), Africa, Eurozone and global macroeconomic and business conditions; the effects of continued
volatility in credit markets; market related risks such as changes in interest rates and foreign exchange
rates; effects of changes in valuation of credit market exposures; changes in valuation of issued securities;
volatility in capital markets; changes in credit ratings of any entities within the Group or any securities
issued by such entities; the potential for one or more countries exiting the Eurozone; the implications of
the results of the 23 June 2016 referendum in the UK and the disruption that may result in the UK and
globally from the withdrawal of the UK from the European Union; the implementation of the strategic
cost programme; and the success of future acquisitions, disposals and other strategic transactions. A
number of these influences and factors are beyond the Group's control. As a result, the Group's actual
future results, dividend payments, and capital and leverage ratios may differ materially from the plans,
goals, expectations and guidance set forth in the Group's forward-looking statements. Additional risks and
factors which may impact the Group's future financial condition and performance are identified in the
Group's filings with the SEC (including, without limitation, in the Joint Annual Report, the Q2 2016
Results Announcement and the Q3 2016 Results Announcement (each as defined in the "Information
87441-3-17448-v13.0
- v-
70-40643095



Incorporated by Reference" section below)), each of which are available on the SEC's website at
http://www.sec.gov.
Subject to the Issuer's obligations under the applicable laws and regulations of the UK in relation to
disclosure and ongoing information, the Issuer undertakes no obligation to update publicly or revise any
forward looking statements, whether as a result of new information, future events or otherwise.

87441-3-17448-v13.0
- vi-
70-40643095



CONTENTS

Page
RISK FACTORS .......................................................................................................................................... 1
INFORMATION INCORPORATED BY REFERENCE ............................................................................ 2
TERMS AND CONDITIONS OF THE NOTES ......................................................................................... 4
THE ISSUERS AND THE GROUP .......................................................................................................... 12
GENERAL INFORMATION .................................................................................................................... 13


87441-3-17448-v13.0

70-40643095



RISK FACTORS
Prospective investors should read the entire Prospectus together with the sections of the Base Prospectus
and the other documents incorporated by reference herein. Investing in the Notes involves certain risks.
The principal risk factors relating to the Notes are discussed under "Risk Factors ­ Risks Relating to the
Notes" on pages 7 to 18 of the Base Prospectus and shall be deemed to be incorporated into and form part
of this Prospectus, as amended as set out below. For risks relating to the Issuer and the Group and their
impact, see the section entitled "Risk review" on pages 86 to 93 of the Joint Annual Report (as defined
below) and the description of the risks relating to an exit of the UK from the European Union ("EU") set
out in the section entitled "Risk Management and principal risks" on page 30 of the Q2 2016 Results
Announcement, each of which is incorporated by reference herein.
The risk factor entitled "Certain Notes may be redeemed prior to maturity" set out under "Risks relating
to the Notes" in the Base Prospectus shall be supplemented to include the following text:
On 23 November 2016, the European Commission published, among other proposals, a proposal to
amend the CRD IV Regulation. Such proposal includes certain requirements in respect of eligible
liabilities, including a requirement for prior consent from the competent authority to any early redemption
or purchase thereof. If the proposal is adopted, the granting of permission by the PRA to a request by the
relevant Issuer to redeem or repurchase the Notes could be subject to the conditions in Article 77 and 78
of the CRD IV Regulation (as so amended), to the extent applicable to the Notes.


87441-3-17448-v13.0
- 1-
70-40643095






INFORMATION INCORPORATED BY REFERENCE
The following information has been filed with the FCA and shall be incorporated in, and form part of, this
Prospectus:
1.
the sections set out below from the base prospectus dated 3 August 2016 with respect to the
£60,000,000,000 Debt Issuance Programme of the Issuer and the Bank as supplemented by
Supplement Number 1 to the base prospectus dated 28 October 2016;
Risk Factors ­ Risks Relating to the Notes
7-18
Final Terms and Drawdown Prospectuses
20
Forms of the Notes
21-29
Terms and Conditions of the Notes
30-66
The Issuers and the Group
78-80
United Kingdom Taxation
81-82
Other Tax Considerations
96
Subscription and Sale
97-101
Transfer Restrictions
102-104
2.
the joint Annual Report of the Issuer and the Bank, as filed with the SEC on Form 20-F on 1
March 2016 in respect of the financial years ended 31 December 2014 and 31 December 2015
(the "Joint Annual Report");
3.
the joint announcement of the Issuer and the Bank relating to the Group Strategy Update, as filed
with the SEC on Form 6-K on 1 March 2016 (the "March 2016 Group Strategy Update");
4.
the Group Reporting Changes 2015 & 2014 Results Restatement Document of the Issuer, as filed
with the SEC on Form 6-K on 15 April 2016 (the "Restatement Document");
5.
the joint unaudited Interim Results Announcement of the Issuer and the Bank, as filed with the
SEC on Form 6-K on 29 July 2016 in respect of the six months ended 30 June 2016 (the "Q2
2016 Results Announcement");
6.
the unaudited Q3 2016 Results Announcement of the Issuer as filed with the SEC on Form 6-K
on 27 October 2016 in respect of the nine months ended 30 September 2016 (the "Q3 2016
Results Announcement"); and
7.
the joint announcement of the Issuer and the Bank relating to the complaint filed by the United
States Department of Justice, as filed with the SEC on Form 6-K on 23 December 2016 (the "23
December 2016 Form 6-K").
The above documents may be inspected as described in paragraph 6 of "General Information" herein. The
documents listed above that have been filed with the SEC are available on the SEC's website at
https://www.sec.gov/cgi-bin/browse-
edgar?company=barclays+plc&owner=exclude&action=getcompany. Any information incorporated by
reference in the documents specified above does not form part of this Prospectus. Any information
contained in any of the documents specified above which is not incorporated by reference in this
Prospectus is either not relevant for prospective investors for the purposes of Article 5(1) of the
Prospectus Directive or is covered elsewhere in this Prospectus. This Prospectus is published on the
website of the Regulatory News Service operated by the London Stock Exchange at
http://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html.
The Issuer has applied International Financial Reporting Standards (IFRS) as issued by the International
Accounting Standards Board and as adopted by the EU in the financial statements incorporated by
reference above. A summary of the significant accounting policies for the Issuer is included in the Joint
Annual Report.
Any statement contained in the Base Prospectus or in any other document incorporated by reference
herein shall be deemed to be modified or superseded for the purpose of this Prospectus to the extent that a
statement contained herein modifies or supersedes such earlier statement (whether expressly, by
implication or otherwise). Any statement so modified or superseded shall not be deemed, except as so
modified or superseded, to constitute a part of this Prospectus. Terms used but not defined in this
87441-3-17448-v13.0
- 2-
70-40643095






Prospectus shall have the same respective meaning as are ascribed to them in the Conditions. This
Prospectus must be read in conjunction with the Base Prospectus and the other documents incorporated
by reference herein.
Full information on the Issuer and the Notes described herein is only available on the basis of a
combination of this Prospectus, the Base Prospectus and any other information incorporated by reference
into this Prospectus.

87441-3-17448-v13.0
- 3-
70-40643095






Document Outline